HIGHLIGHTS
- who: Jean-Franu00e7ois Korobelnik from the Universitu00e9 Rousse University have published the paper: Two-year outcomes of the APOLLON observational study of intravitreal aflibercept monotherapy in France in patients with diabetic macular edema, in the Journal: Scientific Reports Scientific Reports
- what: The authors report findings on the secondary endpoints, which included the mean change in BCVA and central retinal thickness (CRT) between baseline and 24 months, the presence of visible fluid after 24 months, and the mean number of IVT-AFL injections over 24 months. If both eyes were treated at baseline, the study eye . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.